Impact of Exercise on Mitochondria in Cancer Patients.
ICCE-Mito
The Impact of Short-term Exercise Programs on Mitochondrial Activity in Colorectal and Prostate Cancer Patients.
1 other identifier
interventional
15
1 country
1
Brief Summary
The aim is to investigate the impact of prostate and colorectal cancer on mitochondrial quantity and quality along with muscle mass and function and whether this can be modified through the use of a home-based short-term exercise training program. The investigators aim to recruit participants awaiting curative surgery for colorectal and prostate cancer and to assess the variation in baseline mitochondrial activity between them. Participants from both cancer types will then carry out a 4 week home exercise program, this will be randomly allocated to either resistance-based or high-intensity interval training based. Participants will then be re-assessed on the day of their planned surgical procedure to assess the changes effected by the training program. The investigators hypothesize that there will be variation in mitochondrial activity linked to muscle mass across the two cancer types and that home-based exercise programs have the ability to improve mitochondrial activity along with muscle mass.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable prostate-cancer
Started Aug 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 14, 2020
CompletedFirst Posted
Study publicly available on registry
September 22, 2020
CompletedStudy Start
First participant enrolled
August 5, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2024
CompletedApril 29, 2026
November 1, 2023
2.4 years
February 14, 2020
April 28, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Mitochondrial activity across 2 cancer types
Mitochondrial oxidative phosphorylation capacity between colorectal and prostate cancer. Mitochondrial oxidative phosphorylation capacity will be measured according to oxygen consumption determined by the use of a high-definition respirometer. This will then be compared across cancer types and expressed as a ratio of maximal consumption.
Assessed at initial baseline study day across cancer types
Mitochondrial activity change with a short-term home-based exercise program
The effect of either a resistance exercise-based and high-intensity interval training-based home-based training program on mitochondrial function. Mitochondrial oxidative phosphorylation capacity will be measured according to oxygen consumption determined by the use of a high-definition respirometer. The changes seen throughout the treatment will then be expressed as a percentage in order to express the changes seen from the baseline.
Assessed over the 4-weeks prior to planned surgical resection
The altered response to training - type between cancer type.
The differing responses between cancer type to the short-term exercise training. Mitochondrial oxidative phosphorylation capacity will be measured according to oxygen consumption determined by the use of a high-definition respirometer. The changes caused by the training regimen will then be expressed as a percentage in order to express the changes seen from the baseline, and in order to allow comparison between cancer type.
4-weeks
Secondary Outcomes (2)
The difference in muscle-function compared between cancer types, and its change throughout a short-term exercise program.
4-weeks
The effect of cancer types and exercise on myokine expression.
4-weeks
Study Arms (2)
Resistance exercise training group
EXPERIMENTALParticipants randomized to this arm will engage in a 4-week home-based training program with anticipated 12 sessions (3 per week) with participants required to attend a minimum of 9 sessions.
High-intensity interval training group
EXPERIMENTALParticipants randomized to this arm will engage in a 4-week home-based training program with anticipated 12 sessions (3 per week) with participants required to attend a minimum of 9 sessions.
Interventions
Each session will be performed at home, with resistance bands used to provide resistance. Participants will be guided to increase the resistance if over 15 repetitions can be performed prior to fatigue. Weekly contact will be made with participants to encourage participation and to guide the exercise. Each session will include: 2 min warm-up jogging on the spot 2 sets of 12-15 repetitions of: Squats Hip flexion Hip extension Hip abduction Seated row Bench press Lateral raises 2 min jogging on the spot cooldown.
Each session will include: * 2 min warm-up: jogging on the spot * Each of the following exercises performed for 60seconds, interspaced by 90 seconds rest * Star jumps * Standing squats * On-the-spot sprints * Standing squats * Star jumps * 2 min cool-down: jogging on the spot Participants will be contacted weekly to encourage participation and to guide the exercise
Eligibility Criteria
You may qualify if:
- Aged 50 years and over (no upper age limit)
- Male patients
- Histologically confirmed malignancy, radiologically or direct visualisation leading to high clinical suspicion of cancer with planned surgical resection as treatment option (prostate or colorectal).
- Sufficient mobility to be able to complete a home-based exercise program
- Capacity to give informed and written consent
- Ability to travel to the RDH to complete the assessment session
You may not qualify if:
- Current participation in a formal exercise regime
- Inability to complete exercise training
- Inadequate level of the English language to be able to provide consent
- A BMI \<16.5 or \>35 kg/m2
- Active cardiovascular disease:
- Uncontrolled hypertension (BP \> 160/100)
- Angina
- Heart failure (class III/IV)
- Significant arrhythmia
- Right to left cardiac shunt
- Recent cardiac event
- Taking beta-adrenergic blocking agents
- Cerebrovascular disease:
- g. Previous stroke h. Aneurysm (large vessel or intracranial) i. Epilepsy
- Respiratory disease including:
- +5 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Thomas Smart
Derby, Derbyshire, DE22 3NE, United Kingdom
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jon Lund, MD MBBS
Nottingham University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- Due to the nature of the exercise interventions, there will be no masking
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 14, 2020
First Posted
September 22, 2020
Study Start
August 5, 2021
Primary Completion
December 30, 2023
Study Completion
March 30, 2024
Last Updated
April 29, 2026
Record last verified: 2023-11
Data Sharing
- IPD Sharing
- Will not share